Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What your price target. $2?
im loading heavy
* * $OGEN Video Chart 01-14-2021 * *
Link to Video - click here to watch the technical chart video
What is the outstanding OS. Not clear.
Any body idea
Yes it did nicely, good to see
Well it happened news out today traded as high as 1.26 i am holding not flipping. long term 2.00 to 3.00 or higher. Maybe not that long.
Could easily happen,
OGEN is listed on a National Exchange....
not an OTC ticker
It can be traded after hours depending on exchange i believe up to 4 hours after hours.
That is why i believe OGEN will be back above $1.00 shortly and stay above.
Nationally listed stocks require $1.00 minimums and have certain time lines to get back above
How can there be trading now??
OGEN Lots of news out Yesterday, gonna be a coin maker here
https://seekingalpha.com/news/3649721-oragenics-enters-material-transfer-agreement-for-covidminus-19-vaccine-adjuvant?utm_source=otcmarkets&utm_medium=referral
https://www.otcmarkets.com/stock/OGEN/news/story?e&id=1779427
https://www.otcmarkets.com/filing/html?id=14605976&guid=yH6qUePL-zyXcth
I just grabbed a small position here this morning, looking forward to breaking a buck again
I actually took a small position yesterday, just to flip for quick profits. Then when the sell filled I got excited, Lol. Buying more and going long!
$OGEN
Imo this will take off today. Fasten your seatbelts.
Yep, float turned over 4 times yesterday... strange pps action with that volume...
After hours rise in PPS tonight caught my eye
I like the potential here
$OGEN
* * $OGEN Video Chart 01-07-2021 * *
Link to Video - click here to watch the technical chart video
93m buys vs 92m sells + 22m(?).
+33% $0.83: >10x DMAV + >2x float. OGEN: Accumulate.
14 Things: Why Oragenics Shares Rocket Thursday, 01-07-2021.
https://investorplace.com/2021/01/ogen-stock-alert-14-things-to-know-about-oragenics-as-shares-rocket-thursday/?mod=mw_quote_news
the news was great
if we get back over $1 today
tmrw gap up
0.90-0.91 now and counting......
0.82-0.85 cover...let's goooooo!
2nd consecutive day >100m shs traded vs. 20m DMAV.
OGEN +38% on 10x DMAV. Even buys vs. sells.
Grabbed .06 gain on 25k from .84 to .90 for a cool $1500 in walkin around money. lol
Clay and his gang have attacked and shorted this one down once again destroying the run. Think these.83s may be bottom. Hoping it pops once the shorters have had their fill and need to cover
yup to get shorts in
I'm going to pocket $50,000 off from this today! :)
$OGEN is screaming for the top after the company announced a material transfer agreement surrounding a COVID-19 vaccine candidate. https://cnafinance.com/ogen-stock-oragenics-climbs-on-material-transfer-agreement/
Got that $1 break... Should be hitting a lot of scanners now...
Could test/break 52-Week High 2.12 Today!
Yes, $2 very possible
Very bullish stocksrising
$2+ possible here today OGEN
Monster News
$OGEN NEWS Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine Adjuvanthttps://t.co/CtrYIUYm7X pic.twitter.com/afoE287LX0
— 💸 Golden Cross Stocks 💸 (@CrossStocks) January 7, 2021
Followers
|
76
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
834
|
Created
|
01/29/13
|
Type
|
Free
|
Moderators |
President and Chief Executive Officer
Dr. Joslyn was a partner in Lazarus Pharmaceuticals. Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.
Chief Financial Officer
Mr. Sullivan has served as our interim principal executive officer since October 30, 2014 and served as our Chief Financial Officer, Secretary and Treasurer since February 6, 2012. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Group Financial Officer for the Investigative Services and Litigation Consulting Services segment of First Advantage Corporation. Mr. Sullivan is a Florida Certified Public Accountant. He graduated from the Florida State University with a Bachelor of Science in Accounting and a Master of Business Administration.
Senior Vice President of Discovery Research
Dr. Handfield is, the Company’s Senior Vice President of Discovery Research and previously has served as our Director of Research and Development. Prior to joining our Company, Dr. Handfield held a position as Tenured Associate Professor at the Center for Molecular Microbiology and the Department of Oral Biology at the University of Florida College of Dentistry, where he co-invented IVIAT and co-founded ivi Gene Corp. and Epicure Corp. to commercialize this and related technologies. Dr. Handfield holds a B.S. degree in Biochemistry, and a MS degree and PhD in Microbiology and Immunology from the Université Laval College of Medicine in Canada, and did postdoctoral training at the University of Florida.
January 7, 2021
December 29, 2020
December 24, 2020
November 24, 2020
November 20, 2020
November 19, 2020
October 6, 2020
September 28, 2020
September 11, 2020
August 20, 2020
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |